Fig. 7From: High-throughput screening of natural compounds and inhibition of a major therapeutic target HsGSK-3β for Alzheimer’s disease using computational approachesGibbs free energy landscape obtained from first two PCs at 300 K. a HsGSK3β, b HsGSK3β-ANP, c HsGSK3β-ZINC15968620, d HsGSK3β-ZINC15968622, e HsGSK3β-ZINC70704976, and f HsGSK3β-ZINC70707119Back to article page